Detalhe da pesquisa
1.
Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma.
Blood
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713888
2.
A low thrombospondin-1 serum concentration is related to increased bacteremia risk in lymphoma patients treated with BeEAM/BEAM conditioning regimen and autologous stem cell transplantation.
Transpl Infect Dis
; 26(1): e14212, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112043
3.
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms.
Int J Mol Sci
; 25(2)2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38255835
4.
Serum Levels of miR-122-5p and miR-125a-5p Predict Hepatotoxicity Occurrence in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Int J Mol Sci
; 25(8)2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38673940
5.
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(2): 139-150, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642080
6.
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.
Br J Haematol
; 203(5): 792-802, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691005
7.
The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.
Int J Mol Sci
; 24(3)2023 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36769265
8.
An elevated systemic inflammation index is related to an inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory multiple myeloma.
Contemp Oncol (Pozn)
; 27(3): 139-146, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239862
9.
Primary pulmonary Hodgkin's lymphoma mimicking granulomatosis with polyangiitis - a case report of diagnostic and therapeutic dilemmas.
Contemp Oncol (Pozn)
; 27(2): 113-117, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794994
10.
The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications.
Int J Mol Sci
; 22(21)2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769503
11.
Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib.
Mediators Inflamm
; 2020: 1835836, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32587468
12.
MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation.
Biomark Res
; 12(1): 42, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650024
13.
Neutrophil to lymphocyte ratio (NLR) impact on the progression-free survival and overall survival of multiple myeloma patients treated with high-dose chemotherapy and autologous stem cell transplantation.
Leuk Lymphoma
; 64(1): 98-106, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36318865
14.
High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation.
Front Oncol
; 13: 1250355, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37829335
15.
Autoimmune cytopenias in patients with malignant lymphoma: A multicenter report by the Polish Lymphoma Research Group.
Adv Clin Exp Med
; 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014929
16.
Association of low ficolin-2 concentration in cord serum with respiratory distress syndrome in preterm newborns.
Front Immunol
; 14: 1107063, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733481
17.
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry.
Clin Lymphoma Myeloma Leuk
; 23(1): e19-e26, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396583
18.
Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study.
J Clin Med
; 11(19)2022 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233774
19.
Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.
J Clin Med
; 10(21)2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34768548
20.
Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib.
J Clin Med
; 11(1)2021 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35011853